In vivo immunosuppression by targeting a novel protease receptor

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Nature

• Publication date

  1996-03-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/380352A0PMID 8598931
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases.

  1995cited by this paper
• Molecular cloning of effector cell protease receptor-1, a novel cell surface receptor for the protease factor Xa.

  1994cited by this paper
• Protease-dependent T cell activation: ligation of effector cell protease receptor-1 (EPR-1) stimulates lymphocyte proliferation.

  1994cited by this paper
• Molecules involved in T-cell costimulation.

  1993cited by this paper
• The pathogenesis of atherosclerosis: a perspective for the 1990s

  1993cited by this paper
• Differential T cell costimulatory requirements in CD28-deficient mice.

  1993cited by this paper
• Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice.

  1993cited by this paper
• Lymphocyte activation and effector functions. Editorial overview. The role of cell surface molecules.

  1993cited by this paper
• Lymphoproliferative disease in human peripheral blood mononuclear cell- injected SCID mice. I. T lymphocyte requirement for B cell tumor generation

  1992cited by this paper
• Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells.

  1992cited by this paper
• Hemagglutination and graft-versus-host disease in the severe combined immunodeficiency mouse lymphoproliferative disease model.

  1992cited by this paper
• Characterization of hu-PBL-SCID mice with high human immunoglobulin serum levels and graft-versus-host disease.

  1992cited by this paper
• Immunization of hu-PBL–SCID mice and the rescue of human monoclonal Fab fragments through combinatorial libraries

  1992cited by this paper
• Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts.

  1992cited by this paper
• Lymphocyte activation and effector functions.

  1991cited by this paper
• The coagulation cascade: initiation, maintenance, and regulation.

  1991cited by this paper
• Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man

  1991cited by this paper
• Break for SCIDs

  1991cited by this paper
• Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44.

  1991cited by this paper
• Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.

  1991cited by this paper
• Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice

  1990cited by this paper
• Characterization of Epstein-Barr virus-induced lymphoproliferation derived from human peripheral blood mononuclear cells transferred to severe combined immunodeficient mice.

  1990cited by this paper
• On the SCIDs?

  1989cited by this paper
• Transfer of a functional human immune system to mice with severe combined immunodeficiency

  1988cited by this paper
• Activation of T cells by cross‐linking an anti‐CD3 antibody with a second anti‐T cell antibody: mechanism and subset‐specific activation

  1987cited by this paper
• Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modules.

  1985cited by this paper
• Thrombin-stimulated cell division involves proteolysis of its cell surface receptor

  1979cited by this paper

• HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Tissue Factor and Factor VIIa Receptor/Ligand Interactions Induce Proinflammatory Effects in Macrophages

  2016cites this paper
• distinct antiapoptotic functions Three differentially expressed survivin cDNA variants encode proteins with

  2013cites this paper
• hu-PBL-SCID mice : an in vivo model of Epstein-Barr virus-dependent Iymphoproliferative disease

  2011cites this paper
• Blockade of tissue factor-factor X binding attenuates sepsis-induced respiratory and renal failure.

  2006cites this paper
• Fibrin independent proinflammatory effects of tissue factor in experimental crescentic glomerulonephritis.

  2004cites this paper
• Antithrombotic agents in the treatment of severe sepsis

  2002cites this paper
• Antithrombotic Agents in the Management of Sepsis.

  2002cites this paper
• Coagulation and Inflammation in Acute Lung Injury

  2002cites this paper
• Factor Xa-Inhibitor (Dx-9065a) Modulates the Leukocyte-Endothelial Cell Interaction in Endotoxemic Rat

  2002influential citation
• G protein β2 subunit antisense oligonucleotides inhibit cell proliferation and disorganize microtubule and mitotic spindle organization

  2001cites this paper
• Factor Xa-evoked relaxation in rat aorta: involvement of PAR-2.

  2001cites this paper
• Antithrombin III inhibits lymphocyte proliferation, immunoglobulin production and mRNA expression of lymphocyte growth factors (IL-2, gamma-IFN and IL-4) in vitro.

  2001cites this paper
• Three differentially expressed survivin cDNA variants encode proteins with distinct antiapoptotic functions.

  2000cites this paper
• Thrombin and factor Xa enhance neutrophil chemoattractant production after ischemia/reperfusion in the rat liver.

  2000cites this paper
• Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6‐OHDA lesion model depends on the site of administration of the trophic factor

  2000cites this paper
• Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.

  2000cites this paper
• Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin?

  2000cites this paper
• Modulation of hemostatic mechanisms in bacterial infectious diseases.

  2000cites this paper
• Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages.

  1999cites this paper
• Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle

  1999cites this paper
• From Basic Immunology to Immune-Mediated Demyelination

  1999cites this paper
• Immunotherapies for Multiple Sclerosis

  1999cites this paper
• The coagulation pathway and antithrombotic strategies

  1999cites this paper
• Ancylostoma caninum Anticoagulant Peptide Blocks Metastasis In Vivo and Inhibits Factor Xa Binding to Melanoma Cells In Vitro

  1998cites this paper
• Identification of Asp95as the Site of Succinimide Formation in Recombinant Human Glial Cell Line-Derived Neurotrophic Factor

  1998cites this paper
• Antisense oligodesoxynucleotide strategies in renal and cardiovascular disease.

  1998cites this paper
• hu-PBL-SCID mice: an in vivo model of Epstein-Barr virus-dependent lymphoproliferative disease.

  1998cites this paper
• High affinity cross-reacting mAb generated by minimal mimicry: implications for the pathogenesis of anti-nuclear autoantibodies and immunosuppression.

  1998cites this paper
• Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives.

  1997cites this paper
• Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease.

  1997cites this paper
• Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease.

  1997cites this paper
• Cross-linking of protein S bound to lymphocytes promotes aggregation and inhibits proliferation.

  1997cites this paper
• Effector Cell Protease Receptor-1, a Platelet Activation-dependent Membrane Protein, Regulates Prothrombinase-catalyzed Thrombin Generation*

  1997cites this paper
• Interactions of neutrophils and coagulation proteins.

  1997cites this paper
• Protein S is inducible by interleukin 4 in T cells and inhibits lymphoid cell procoagulant activity.

  1997cites this paper
• What's new in transplantation.

  1997cites this paper
• More inflammatory effects of protease receptors.

  1997cites this paper
• Control of T lymphocyte signal transduction through clonal anergy

  1996cites this paper
• Educating effector T cells

  1996cites this paper
• Immune response in ADEPT

  1996cites this paper
• Transplantation biology. Educating effector T cells.

  1996cites this paper